Your browser doesn't support javascript.
loading
Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cells.
Nakajima, Masao; Sakoda, Yukimi; Adachi, Keishi; Nagano, Hiroaki; Tamada, Koji.
Affiliation
  • Nakajima M; Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Sakoda Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Adachi K; Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Nagano H; Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Tamada K; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Cancer Sci ; 110(10): 3079-3088, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31432594

Full text: 1 Database: MEDLINE Main subject: Immunotherapy, Adoptive / Single-Chain Antibodies / Programmed Cell Death 1 Receptor / Receptors, Chimeric Antigen / Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Sci Year: 2019 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Immunotherapy, Adoptive / Single-Chain Antibodies / Programmed Cell Death 1 Receptor / Receptors, Chimeric Antigen / Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Sci Year: 2019 Type: Article Affiliation country: Japan